⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for EndoPredict® Extended Endocrine Trial (EXET)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: EndoPredict® Extended Endocrine Trial (EXET)

Official Title: EndoPredict® Extended Endocrine Trial (EXET): A Prospective Registry to Evaluate the Impact of EndoPredict® Test on Extended Endocrine Treatment Decisions and Patient Outcomes.

Study ID: NCT04016935

Interventions

Observational

Study Description

Brief Summary: The purpose of this study is to evaluate the impact of using EndoPredict® clinically to inform treatment decisions for extended endocrine therapy, and the subsequent impact on patient outcomes.

Detailed Description: The EndoPredict® molecular test is validated to predict late distant recurrence after 5 years of endocrine therapy in women with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) early stage breast cancer, with or without treatment with adjuvant chemotherapy. The test provides an individualized EPclin score based on the tumor gene expression, tumor size and nodal status, and categorizes patients as High or Low risk of distant recurrence. The primary objective of this study is to evaluate the distant recurrence-free survival (DRFS) at 5-10 years in patients with ER+/HER2- early stage breast cancer with EPclin Low scores that did not extend endocrine therapy. Data collection is prospective and patient enrollment is expected to occur over 24 months. The study will enroll patients who are near the 5-year post-diagnosis time point when decisions on extending endocrine therapy are being made. Patient breast cancer tumors, stored from surgical collection after initial diagnosis, will be tested with EndoPredict and a report generated. The provider will convey the report results to the patient and establish a treatment plan to continue or forgo endocrine therapy. Patients will then be followed for 6 years with data collection every year, and outcomes (distant and local disease recurrence, second primary breast cancer, etc.) recorded. The associations between outcomes and treatment, EPclin score and risk category, EP molecular score, and clinicopathologic features will be investigated in all patients and in subpopulations (node negative, node positive, treated with or without chemotherapy, etc.).

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Providence, Burbank, California, United States

Sutter Hematology and Oncology, Roseville, California, United States

Florida Cancer Specialists, Fort Myers, Florida, United States

Florida Cancer Specialists, Saint Petersburg, Florida, United States

Florida Cancer Specialists, Tallahassee, Florida, United States

Florida Cancer Specialists, West Palm Beach, Florida, United States

Columbus Regional Research Institute, Columbus, Georgia, United States

AON Hematology Oncology Clinic, Baton Rouge, Louisiana, United States

Minnesota Oncology Hematology, Minneapolis, Minnesota, United States

New York Oncology Hematology, Albany, New York, United States

New York Oncology Hematology, Albany, New York, United States

New York Oncology Hematology, Clifton Park, New York, United States

Hematology Oncology Associates of Central New York, PC, East Syracuse, New York, United States

Akron General Medical Center, Akron, Ohio, United States

Summa Health, Akron, Ohio, United States

UPMC Hillman Cancer Center Beaver, Beaver, Pennsylvania, United States

UPMC Hillman Cancer Center Upper St. Clair, Bethel Park, Pennsylvania, United States

Butler Health System Medical Oncology, Butler, Pennsylvania, United States

UPMC Hillman Cancer Center - Moon, Coraopolis, Pennsylvania, United States

UPMC Passavant North Cranberry (OHA), Cranberry Township, Pennsylvania, United States

UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States

UPMC Hillman Cancer Center Horizon, Farrell, Pennsylvania, United States

UPMC Hillman Cancer Center Greenville, Greenville, Pennsylvania, United States

UPMC Hillman Cancer Center Indiana, Indiana, Pennsylvania, United States

UPMC Hillman Cancer Center Arnold Palmer at Norwin, Irwin, Pennsylvania, United States

UPMC Hillman Cancer Center Murtha, Johnstown, Pennsylvania, United States

UPMC Hillman Cancer McKeesport, McKeesport, Pennsylvania, United States

Ortenzio Cancer Center, Mechanicsburg, Pennsylvania, United States

UPMC Hillman Cancer Center Monroeville, Monroeville, Pennsylvania, United States

UPMC Hillman Cancer Center Arnold Palmer at Mt. Pleasant, Mount Pleasant, Pennsylvania, United States

UPMC Hillman Cancer Center - Natrona Heights, Natrona Heights, Pennsylvania, United States

UPMC Hillman Cancer Center New Castle, New Castle, Pennsylvania, United States

Allegheny Health Network, Pittsburgh, Pennsylvania, United States

Magee-Women's Hospital of UPMC, Pittsburgh, Pennsylvania, United States

University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States

UPMC Hillman Cancer Center St Margaret, Pittsburgh, Pennsylvania, United States

UPMC Hillman Cancer Center Passavant (HOA), Pittsburgh, Pennsylvania, United States

UPMC Hillman Cancer Center Passavant (OHA), Pittsburgh, Pennsylvania, United States

UPMC - St. Clair Hospital - Integrated Cancer Services, Pittsburgh, Pennsylvania, United States

UPMC Hillman Cancer Center Northwest, Seneca, Pennsylvania, United States

UPMC Hillman Cancer Center Uniontown, Uniontown, Pennsylvania, United States

UPMC Hillman Cancer Center Washington, Washington, Pennsylvania, United States

UPMC Hillman Cancer Center Jefferson, West Mifflin, Pennsylvania, United States

UPMC Hillman Cancer Center Williamsport, Williamsport, Pennsylvania, United States

UPMC Memorial, York, Pennsylvania, United States

Carolina Blood and Cancer Care Associates, Lancaster, South Carolina, United States

Carolina Blood and Cancer Care Associates, Rock Hill, South Carolina, United States

Baptist Cancer Center, Memphis, Tennessee, United States

Tennessee Oncology, Nashville, Tennessee, United States

Texas Oncology Sammons Cancer Center, Dallas, Texas, United States

Hope Cancer of Texas, Tyler, Texas, United States

Texas Oncology, Tyler, Texas, United States

Contact Details

Name: Joyce O'Shaunessey, MD

Affiliation: US Oncology

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: